Atlas Trials

Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder

Clinical trial NCT00694798 · COMPLETED

Trial details

NCT number
NCT00694798
Sponsor
Cadila Pharnmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2008-10-01
Primary completion
2011-07-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.